Using suction electrodes, photocurrent responses to 100-ms saturating flashes were recorded from isolated retinal rods of the larval-stage tiger salamander (Ambystoma tigrinum). The delay period (7" c ) that preceded recovery of the dark current by a criterion amount (3 pA) was analyzed in relation to the flash intensity (If), and to the corresponding fractional bleach (R* 0 /R lol ) of the visual pigment; Rl/R lol was compared with R*/R lol , the fractional bleach at which the peak level of activated transducin approaches saturation. Over an approximately 8 In unit range of If that included the predicted value of R*/R lol , T c increased linearly with In If. Within the linear range, the slope of the function yielded an apparent exponential time constant (T C ) of 1.7 ± 0.2 s (mean ± S.D.). Background light reduced the value of T c measured at a given flash intensity but preserved a range over which T c increased linearly with In If-, the linear-range slope was similar to that measured in the absence of background light. The intensity dependence of T c resembles that of a delay (T d ) seen in light-scattering experiments on bovine retinas, which describes the period of essentially complete activation of transducin following a bright flash; the slope of the function relating T d and In flash intensity is thought to reflect the lifetime of photoactivated visual pigment (/?*) (Pepperberg et al., 1988; Kahlert et al., 1990). The present data suggest that the electrophysiological delay has a similar basis in the deactivation kinetics of / ? ' , and that T C represents T R >, the lifetime of R* in the phototransduction process. The results furthermore suggest a preservation of the "dark-adapted" value of T R * within the investigated range of background intensity.
Rhodopsin is a member of an ancient class of receptors that transduce signals through their interaction with guanine nucleotide-binding proteins (G proteins). We have mapped the sites of interaction of rhodopsin with its G protein, which by analogy suggests how other members of this class of receptors may interact with their G proteins. Three regions of rhodopsin's cytoplasmic surface interact with the rod cell G protein transducin (Ga. These are (i) the second cytoplasmic loop, which connects rhodopsin helices m and IV, (U) the third cytoplasmic loop, which connects rhodopsin helices V and VI, and (iu) a putative fourth cytoplasmic loop formed by amino acids 310-321, as the carboxyl-terminal sequence emerges from helix VII and anchors to the lipid bilayer via palmitoylcysteines 322 and 323. Evidence for these regions of interaction of rhodopsin and Gt comes from the ability of synthetic peptides comprising these regions to compete with metarhodopsin II for binding to Gt. A spectroscopic assay that measures the "extra MIU" caused by Gt binding was used to measure the extent of binding of Gt in the presence of competing peptides. The three peptides corresponding to the second, third, and fourth cytoplasmic loops competed effectively with metarhodopsin H, exhibiting Kd values in the 2 jtM range; 11 additional peptides comprising all remaining surface regions of rhodopsin failed to compete even at 200 ,M. Any two peptides that were effective competitors showed a synergistic effect, having 15 times higher effectiveness when mixed than when assayed separately. A mathematical model was developed to describe this behavior.Rhodopsin is the best-studied receptor protein of that class of signal-transducing receptors that act via guanine nucleotidebinding proteins, or G proteins. Other members of this class include the adrenergic receptors (1), the muscarinic acetylcholine receptors (2), the substance K receptor (3) Gt. We previously showed (9) that selected peptides from the sequence of the Gt a subunit (Gta) can interfere with binding of Gt to photolyzed rhodopsin, thus allowing assignment of these peptides to the region of the Gta sequence that binds to rhodopsin. In the work described here, we tested peptides from the rhodopsin sequence in order to see which ones reduce the level of extra MII. Such peptides presumably would do so by simulating a region ofrhodopsin's surface that interacts with Gt, thus interfering with Gt binding to MII. MATERIALS AND METHODSSpectrophotometric Assay. Binding of Gt to MII was measured as in refs. 7-9. The assay was performed at pH 8 and 4°C, conditions under which only a small, control amount of MII is formed in the absence of Gt. The full extra MII signal in the presence of Gt corresponds to a 60% MII fraction ofthe total photoexcited rhodopsin. The final levels of MII formation minus the control level (no Gt present) are a direct measure of the rhodopsin-Gt complexes formed. When normalized to the undisturbed full extra MII signal, they yield the relative amount of Gt that is ...
On stimulation by green flashes, the isolated, aspartate-treated bovine retina exhibits transient changes in the scattering of near-infrared (880 nm) light. A single com-
A model of transducin activation is constructed from its partial reactions (formation of metarhodopsin II, association, and dissociation of the rhodopsin-transducin complex). The kinetic equations of the model are solved both numerically and, for small photoactivation, analytically. From data on the partial reactions in vitro, rate and activation energy profile of amplified transducin turnover are modeled and compared with measured light-scattering signals of transducin activation in intact retinal rods. The data leave one free parameter, the rate of association between transducin and rhodopsin. Best fit is achieved for an activation energy of 35 kJ/mol, indicating lateral membrane diffusion of the proteins as its main determinant. The absolute value of the association rate is discussed in terms of the success of collisions to form the catalytic complex. It is greater than 30% for the intact retina and 10 times lower after permeabilization with staphylococcus aureus alpha-toxin. Dissociation rates for micromolar guanosinetriphosphale (GTP) (Kohl, B., and K. P. Hofmann, 1987. Biophys. J. 52:271-277) must be extrapolated linearly up to the millimolar range to explain the rapid transducin turnover in situ. This is interpreted by an unstable rhodopsin-transducin-GTP transient state. At the time of maximal turnover after a flash, the rate of activation is determined as 30, 120, 800, 2,500, and 4,000 activated transducins per photoactivated rhodopsin and second at 5, 10, 20, 30, 37 degrees C, respectively.
Bleaching of rhodopsin markedly desensitizes the vertebrate visual system during a subsequent period of dark adaptation. Previous studies have indicated an origin of bleaching desensitization in the visual pigment itself, but have not identified the mechanism of action. A candidate for the site at which densensitization is initially expressed is the activation of transducin (formation of T*) on the rod disk membranes; this reaction directly involves rhodopsin in its photoactivated (R*) form and mediates initial amplification of the visual signal (reviewed in refs 7-9). We have analysed the effect of bleaching on the sensitivity of a flash-induced light-scattering signal known to monitor the disk-based amplifier, and which has been established as specifically monitoring transducin activation. We have recorded this signal from functioning retinal rods in situ ('ATR' signal) and find that bleaches inducing a pronounced, sustained loss in rod electrophysiological sensitivity do not alter the sensitivity of the ATR response after correction for reduced quantum catch. Our results indicate that the biochemical gain of the R*----T* transduction stage remains unchanged in the presence of bleached pigment and implicate a subsequent reaction as the first to show a sustained, bleaching-dependent gain reduction.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.